Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Neogenomics Inc (NEO)

Neogenomics Inc (NEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,798,558
  • Shares Outstanding, K 117,048
  • Annual Sales, $ 444,450 K
  • Annual Income, $ 4,170 K
  • 60-Month Beta 0.68
  • Price/Sales 12.95
  • Price/Cash Flow 111.53
  • Price/Book 7.92
Trade NEO with:

Options Overview

Details
  • Implied Volatility 52.01%
  • Historical Volatility 44.79%
  • IV Percentile 42%
  • IV Rank 29.13%
  • IV High 82.19% on 04/21/20
  • IV Low 39.61% on 08/21/20
  • Put/Call Vol Ratio 0.17
  • Today's Volume 471
  • Volume Avg (30-Day) 388
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 11,714
  • Open Int (30-Day) 6,867

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.01
  • Number of Estimates 3
  • High Estimate 0.01
  • Low Estimate -0.03
  • Prior Year -0.04
  • Growth Rate Est. (year over year) +75.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
43.34 +14.19%
on 03/30/21
52.84 -6.34%
on 03/17/21
-0.71 (-1.41%)
since 03/16/21
3-Month
40.75 +21.45%
on 03/05/21
61.57 -19.62%
on 02/16/21
-3.29 (-6.23%)
since 01/15/21
52-Week
25.19 +96.47%
on 06/01/20
61.57 -19.62%
on 02/16/21
+21.31 (+75.62%)
since 04/16/20

Most Recent Stories

More News
Abaxx Technologies Inc. graduates to the OTCQX Market

Abaxx Technologies Inc., (ABXX:NEO)(ABXXF:OTCQX) ("Abaxx" or the "Company"), a financial software (fintech) company, majority shareholder of Abaxx Singapore Pte. Ltd., the Abaxx Commodity Exchange (ACX),...

RILY : 70.11 (+1.67%)
ABXXF : 3.1400 (-1.65%)
NEO : 49.43 (-0.22%)
S&P Reaches New Record Ahead of Big Bank Reports

S&P Reaches New Record Ahead of Big Bank Reports

JPM : 153.00 (+0.55%)
WFC : 43.75 (+3.57%)
GS : 341.47 (+0.86%)
VMC : 176.54 (+1.02%)
AXLA : 4.24 (-0.47%)
NVAX : 219.69 (+8.71%)
TWST : 134.93 (-5.02%)
TAL : 59.81 (+4.64%)
ILMN : 396.75 (-1.30%)
NEO : 49.43 (-0.22%)
HTHT : 56.97 (+2.37%)
LVS : 61.00 (-0.47%)
TDC : 39.60 (+0.87%)
JNJ : 161.94 (+0.97%)
NeoGenomics to Participate in the 20th Annual Needham Virtual Healthcare Conference

FT. MYERS, FL / ACCESSWIRE / April 13, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced...

NEO : 49.43 (-0.22%)
NeoGenomics Schedules its First Quarter 2021 Earnings Release for May 5, 2021

FT MYERS, FL / ACCESSWIRE / April 7, 2021 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing and global contract research services, announced today that it plans to...

NEO : 49.43 (-0.22%)
Strength Seen in NeoGenomics (NEO): Can Its 7.9% Jump Turn into More Strength?

NeoGenomics (NEO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

NEO : 49.43 (-0.22%)
Resilient Dow Stays at Record Despite Margin Call Volatility

Resilient Dow Stays at Record Despite Margin Call Volatility

VLO : 73.07 (+2.35%)
TMHC : 31.92 (+0.92%)
DB : 12.48 (+1.55%)
AXL : 9.48 (+0.74%)
AA : 35.57 (+8.31%)
CVA : 13.69 (-0.58%)
GRPN : 49.20 (-3.79%)
REZI : 28.65 (-1.10%)
X : 22.59 (+1.99%)
TAL : 59.81 (+4.64%)
NEO : 49.43 (-0.22%)
TDC : 39.60 (+0.87%)
CS : 10.78 (+0.19%)
NMR : 5.40 (+0.37%)
BetterLife Added to Horizons Psychedelic Stock Index ETF

BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB : BETRF / FRA: NPAU) is pleased to announce that it has been added to the Horizons Psychedelic Stock Index ETF (PSYK : NEO), the...

BETRF : 0.6547 (-0.88%)
NEO : 49.43 (-0.22%)
Algernon Pharmaceuticals Announces its Addition to the Market's First Psychedelic Stock Index ETF

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the "Company" or "Algernon") a clinical stage pharmaceutical development company is pleased to announce that it has been added...

AGN.CN : 0.160 (+3.23%)
AGNPF : 0.1284 (+0.63%)
NEO : 49.43 (-0.22%)
Horizons ETFs Completes Rebalance of World's First Psychedelics ETF

Horizons ETFs Completes Rebalance of World's First Psychedelics ETF

NEO : 49.43 (-0.22%)
NeoGenomics Agrees to Acquire Trapelo Health

Clinical Decision Support to Enable Precision Oncology

NEO : 49.43 (-0.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

3rd Resistance Point 50.94
2nd Resistance Point 50.56
1st Resistance Point 50.05
Last Price 49.43
1st Support Level 49.16
2nd Support Level 48.78
3rd Support Level 48.27

See More

52-Week High 61.57
Last Price 49.43
Fibonacci 61.8% 47.67
Fibonacci 50% 43.38
Fibonacci 38.2% 39.09
52-Week Low 25.19

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar